Compare NTB & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NTB | GRDN |
|---|---|---|
| Founded | 1858 | 2004 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Retail-Drug Stores and Proprietary Stores |
| Sector | Finance | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 2016 | 2024 |
| Metric | NTB | GRDN |
|---|---|---|
| Price | $50.77 | $30.95 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $50.67 | $32.00 |
| AVG Volume (30 Days) | 164.2K | ★ 293.5K |
| Earning Date | 02-09-2026 | 11-10-2025 |
| Dividend Yield | ★ 4.00% | N/A |
| EPS Growth | ★ 17.07 | N/A |
| EPS | ★ 5.27 | 0.28 |
| Revenue | $599,452,000.00 | ★ $1,389,638,000.00 |
| Revenue This Year | $4.72 | $19.50 |
| Revenue Next Year | N/A | $0.48 |
| P/E Ratio | ★ $9.49 | $111.10 |
| Revenue Growth | 4.60 | ★ 18.68 |
| 52 Week Low | $34.77 | $17.78 |
| 52 Week High | $52.11 | $37.43 |
| Indicator | NTB | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 61.90 | 55.34 |
| Support Level | $49.38 | $30.68 |
| Resistance Level | $51.32 | $31.96 |
| Average True Range (ATR) | 0.91 | 1.11 |
| MACD | -0.25 | -0.07 |
| Stochastic Oscillator | 55.05 | 60.10 |
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, Cayman Islands, the Channel Islands and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.